SCHEMBL8279676

SCHEMBL8279676

C[C@H](NC(=O)C(N)CCC(=O)O)B(O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP9 Q86TI2 12/20 1.00
▸ DPP4 P27487 11/20 1.00
▸ DPP8 Q6V1X1 10/20 1.00
▸ DPP7 Q9UHL4 9/20 0.53
▸ FAP Q12884 1/20 0.53
▸ GABRP O00591 2/20 0.47
▸ GABRD O14764 2/20 0.47
▸ GABRA1 P14867 2/20 0.47
▸ GABRB1 P18505 2/20 0.47
▸ GABRG2 P18507 2/20 0.47
▸ GABRB3 P28472 2/20 0.47
▸ GABRA5 P31644 2/20 0.47
▸ GABRA3 P34903 2/20 0.47
▸ GABRA2 P47869 2/20 0.47
▸ GABRB2 P47870 2/20 0.47
▸ GABRA4 P48169 2/20 0.47
▸ GABRE P78334 2/20 0.47
▸ GABRA6 Q16445 2/20 0.47
▸ GABRG1 Q8N1C3 2/20 0.47
▸ GABRG3 Q99928 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10310176 1.00 DPP9 (1.00) DPP9DPP4DPP8DPP7FAP
SCHEMBL13914365 0.88 DPP9 (0.79) DPP9DPP4DPP8DPP7FAP
SCHEMBL10280921 0.82 DPP4 (0.69) DPP9DPP4DPP8GABRPGABRD
SCHEMBL8279681 0.80 DPP9 (0.67) DPP9DPP4DPP8DPP7GABRP
SCHEMBL15434855 0.80 DPP9 (0.67) DPP9DPP4DPP8DPP7GABRP
SCHEMBL751142 0.79 DPP4 (0.65) DPP9DPP4DPP8GABRPGABRD
SCHEMBL29415456 0.79 DPP4 (0.65) DPP9DPP4DPP8GABRPGABRD
SCHEMBL27996817 0.79 DPP4 (0.65) DPP9DPP4DPP8GABRPGABRD
SCHEMBL751143 0.79 DPP4 (0.65) DPP9DPP4DPP8GABRPGABRD
SCHEMBL10162444 0.77 DPP4 (0.63) DPP9DPP4DPP8GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110218142-A1 Inhibitors of Dipeptidylpeptidase IV TRUSTEES OF TUFTS COLLEGE (US) 2011-09-08 — — US disclosed
US-20090062235-A1 Inhibitors of Dipeptidylpeptidase IV TRUSTEES OF TUFTS COLLEGE (US) 2009-03-05 — — US disclosed
WO-2005082348-A2 INHIBITORS OF DIPEPTIDYLPEPTIDASE IV FOR REGULATING GLUCOSE METABOLISM TRUSTEES OF TUFTS COLLEGE (US) 2005-09-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062235-A1 Inhibitors of Dipeptidylpeptidase IV DPP4, DPP3, DPP7 DPP9 8/4885DPP4 1/4885DPP8 9/4885
US-20110218142-A1 Inhibitors of Dipeptidylpeptidase IV DPP4, DPP3, DPP7 DPP9 8/4885DPP4 1/4885DPP8 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback